Ametek
AME NYSE Electrical Components & Equipment Financials FY2016βFY2025
Ametek's revenue rose 6.6% to $7.4 billion in fiscal 2025. Its operating margin was 25.8%, up from 25.6% a year earlier. Free cash flow was $1.7 billion, down 1.8%. It paid out $719 million in dividends and buybacks, 43% of free cash flow. The diluted share count fell 0.4%.
What Ametek does
No business description yet.
- Legal name
- AMETEK, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001037868-26-000016
0001037868
Revenue and margins
Ametek had $7.4B of revenue in fiscal 2025, up 6.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 12.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.7B in fiscal 2025, 22.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ametek returned $719M to shareholders in fiscal 2025, 43% of free cash flow. The diluted share count fell 0.4%.
Value Ametek yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.8B and divides by 231.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 35.1x Β· peers 35.2x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Ametek can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $347M | $345M | $410M | $374M | $458M |
| Debt incl. finance leases | $2.5B | $2.4B | $3.3B | $2.1B | $2.3B |
| Net debt / EBITDA | 1.4x | 1.1x | 1.4x | 0.8x | 0.8x |
| Debt / equity | 0.4x | 0.3x | 0.4x | 0.2x | 0.2x |
| Interest coverage | 16.3x | 18.0x | 20.9x | 15.8x | 23.5x |
| Current ratio | 1.4x | 1.6x | 1.0x | 1.2x | 1.1x |
| Quick ratio | 0.9x | 1.0x | 0.6x | 0.8x | 0.7x |
| Total assets | $11.9B | $12.4B | $15.0B | $14.6B | $16.1B |
| Total liabilities | $5.0B | $5.0B | $6.3B | $5.0B | $5.4B |
| Shareholders' equity | $6.9B | $7.5B | $8.7B | $9.7B | $10.6B |
| Net debt (β = net cash) | $2.2B | $2.0B | $2.9B | $1.7B | $1.8B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$1.0M
1 insider
Sold, 12 months
$34.8M
7 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Nick L StanageDirector | Bought | 4,000 | $255.85 | $1.0M | Form 4 |
| Aug 7, 2026 | David F. HermancePresident - Electromechanical | Sold | 6,608 | $254.00 | $1.7M | Form 4 |
| Mar 24, 2026 | Thomas A AmatoDirector | Sold | 530 | $216.78 | $0.1M | Form 4 |
| Dec 22, 2025 | Thomas M MontgomerySr. VP. - Comptroller | Sold | 6,388 | $205.05 | $1.3M | Form 4 |
| Dec 15, 2025 | Thomas C MarecicPres. - Electronic Instruments | Sold | 14,310 | $202.11 | $2.9M | Form 4 |
| Dec 12, 2025 | David A ZapicoChief Executive Officer, Director | Sold | 28,390 | $201.76 | $5.7M | Form 4 |
| Nov 25, 2025 | David A ZapicoChief Executive Officer, Director | Sold | 88,000 | $196.39 | $17.3M | Form 4 |
| Nov 12, 2025 | Emanuela SperanzaChief Commercial Officer | Sold | 2,700 | $200.00 | $0.5M | Form 4 |
| Oct 31, 2025 | Ronald J OscherChief Administrative Officer | Sold | 26,290 | $200.05 | $5.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 5 / 9 | 7 / 9 |
| Accruals ratio | β3.1% | β3.1% | β2.1% |
| Altman Z'' | 4.35 | 5.54 | 5.41 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Ametek AME | $55.2B | 6.6% | 25.8% | 22.6% | 13.2% | 35.1x | 7 | |
| Rockwell Automation ROK | $47.6B | 0.9% | 20.4% | 16.3% | 20.9% | 39.9x | 8 | Compare β |
| Regal Rexnord RRX | $9.9B | β1.7% | 11.5% | 15.1% | 4.8% | 30.5x | 8 | Compare β |
| Vertiv VRT | $76.3B | 27.7% | 17.9% | 18.5% | 30.2% | 44.0x | 6 | Compare β |
| Acuity Brands AYI | $9.9B | 6.8% | 15.4% | 16.1% | 17.9% | 18.7x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.8B | $4.3B | $4.8B | $5.2B | $4.5B | $5.5B | $6.2B | $6.6B | $6.9B | $7.4B |
| Gross profit | $1.3B | $1.4B | $1.7B | $1.8B | $1.5B | $1.9B | $2.1B | $2.4B | $2.5B | $2.7B |
| Research and development | $112M | $130M | $141M | $162M | $159M | $194M | $199M | $221M | $237M | $236M |
| Operating income | $791M | $904M | $1.1B | $1.2B | $1.0B | $1.3B | $1.5B | $1.7B | $1.8B | $1.9B |
| Interest expense | $94.3M | $98.0M | $82.2M | $88.5M | $86.1M | $80.4M | $83.2M | $81.8M | $113M | $81.3M |
| Pretax income | $693M | $797M | $988M | $1.1B | $1.1B | $1.2B | $1.4B | $1.6B | $1.7B | $1.8B |
| Income tax | $181M | $115M | $210M | $209M | $210M | $233M | $269M | $293M | $285M | $318M |
| Net income | $512M | $682M | $778M | $861M | $872M | $990M | $1.2B | $1.3B | $1.4B | $1.5B |
| Diluted EPS | $2.19 | $2.94 | $3.34 | $3.75 | $3.77 | $4.25 | $5.01 | $5.67 | $5.93 | $6.40 |
| Diluted shares | 0.23B | 0.23B | 0.23B | 0.23B | 0.23B | 0.23B | 0.23B | 0.23B | 0.23B | 0.23B |
| Cash flow | ||||||||||
| Cash from operations | $757M | $833M | $926M | $1.1B | $1.3B | $1.2B | $1.1B | $1.7B | $1.8B | $1.8B |
| Capital expenditure | $63.3M | $75.1M | $82.1M | $102M | $74.2M | $111M | $139M | $136M | $127M | $130M |
| Free cash flow | $694M | $758M | $843M | $1.0B | $1.2B | $1.0B | $1.0B | $1.6B | $1.7B | $1.7B |
| Depreciation and amortization | $180M | $183M | $200M | $234M | $255M | $292M | $319M | $338M | $383M | $423M |
| Stock-based compensation | $22.0M | $25.1M | $27.3M | $40.4M | $41.6M | $46.1M | $47.4M | $46.2M | $47.9M | $47.8M |
| Acquisitions | $391M | $557M | $1.1B | $1.1B | $117M | $2.0B | $430M | $2.2B | $118M | $933M |
| Share buybacks | $336M | $6.9M | $368M | $11.9M | $4.7M | $14.7M | $333M | $7.8M | $212M | $434M |
| Dividends paid | $83.3M | $82.7M | $129M | $128M | $165M | $185M | $202M | $230M | $259M | $285M |
| Dividends and buybacks | $419M | $89.6M | $497M | $139M | $170M | $199M | $535M | $238M | $471M | $719M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $717M | $646M | $354M | $393M | $1.2B | $347M | $345M | $410M | $374M | $458M |
| Total debt | $2.3B | $2.2B | $2.6B | $2.8B | $2.4B | $2.5B | $2.4B | $3.3B | $2.1B | $2.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $1.9B | $1.9B | $1.8B | $2.0B | $2.5B | $2.1B | $2.5B | $2.8B | $2.6B | $3.0B |
| Current liabilities | $924M | $1.1B | $1.3B | $1.4B | $1.1B | $1.6B | $1.6B | $2.9B | $2.1B | $2.8B |
| Inventory | $492M | $541M | $625M | $625M | $559M | $769M | $1.0B | $1.1B | $1.0B | $1.1B |
| Property and equipment, net | $473M | $493M | $554M | $549M | $527M | $617M | $636M | $891M | $819M | $855M |
| Total assets | $7.1B | $7.8B | $8.7B | $9.8B | $10.4B | $11.9B | $12.4B | $15.0B | $14.6B | $16.1B |
| Total liabilities | $3.8B | $3.8B | $4.4B | $4.7B | $4.4B | $5.0B | $5.0B | $6.3B | $5.0B | $5.4B |
| Shareholders' equity | $3.3B | $4.0B | $4.2B | $5.1B | $5.9B | $6.9B | $7.5B | $8.7B | $9.7B | $10.6B |
| Margins | ||||||||||
| Gross margin | 32.7% | 33.5% | 34.3% | 34.7% | 34.0% | 34.5% | 34.9% | 36.1% | 35.7% | 36.0% |
| Operating margin | 20.6% | 21.0% | 22.2% | 22.8% | 22.6% | 23.6% | 24.4% | 25.9% | 25.6% | 25.8% |
| EBITDA margin | 25.3% | 25.3% | 26.3% | 27.4% | 28.3% | 28.9% | 29.6% | 31.0% | 31.2% | 31.5% |
| Net margin | 13.3% | 15.9% | 16.1% | 16.7% | 19.2% | 17.9% | 18.9% | 19.9% | 19.8% | 20.0% |
| FCF margin | 18.1% | 17.6% | 17.4% | 19.6% | 26.6% | 18.9% | 16.4% | 24.2% | 24.5% | 22.6% |
| Returns | ||||||||||
| Return on capital | 12.1% | 14.8% | 14.0% | 13.5% | 11.3% | 13.1% | 13.1% | 13.2% | 12.8% | 13.2% |
| Return on capital employed | 13.4% | 14.1% | 15.3% | 14.9% | 11.6% | 13.3% | 14.2% | 14.8% | 14.4% | 14.8% |
| Return on equity | 15.7% | 18.7% | 18.8% | 18.4% | 15.8% | 15.4% | 16.2% | 16.2% | 15.0% | 14.6% |
| Return on assets | 7.4% | 9.2% | 9.5% | 9.3% | 8.6% | 8.9% | 9.5% | 9.6% | 9.3% | 9.6% |
| Growth | ||||||||||
| Revenue growth | β3.4% | 12.0% | 12.7% | 6.5% | β12.0% | 22.2% | 10.9% | 7.3% | 5.2% | 6.6% |
| Net income growth | β13.3% | 33.1% | 14.2% | 10.7% | 1.3% | 13.5% | 17.1% | 13.3% | 4.8% | 7.6% |
| EPS growth | β10.6% | 34.3% | 13.6% | 12.3% | 0.5% | 12.7% | 17.9% | 13.2% | 4.6% | 7.9% |
| FCF growth | 14.9% | 9.3% | 11.2% | 20.0% | 19.2% | β13.0% | β3.8% | 58.3% | 6.4% | β1.8% |
| Share count change | β3.3% | β0.8% | 0.4% | β1.4% | 0.8% | 0.7% | β0.6% | β0.0% | 0.3% | β0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.7x | 1.4x | 1.8x | 1.7x | 0.9x | 1.4x | 1.1x | 1.4x | 0.8x | 0.8x |
| Debt / equity | 0.7x | 0.5x | 0.6x | 0.5x | 0.4x | 0.4x | 0.3x | 0.4x | 0.2x | 0.2x |
| Interest coverage | 8.4x | 9.2x | 13.1x | 13.3x | 11.9x | 16.3x | 18.0x | 20.9x | 15.8x | 23.5x |
| Current ratio | 2.1x | 1.7x | 1.5x | 1.4x | 2.3x | 1.4x | 1.6x | 1.0x | 1.2x | 1.1x |
| Quick ratio | 1.6x | 1.2x | 1.0x | 1.0x | 1.8x | 0.9x | 1.0x | 0.6x | 0.8x | 0.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.7% | 1.8% | 1.7% | 2.0% | 1.6% | 2.0% | 2.3% | 2.1% | 1.8% | 1.8% |
| Stock comp / revenue | 0.6% | 0.6% | 0.6% | 0.8% | 0.9% | 0.8% | 0.8% | 0.7% | 0.7% | 0.7% |
| Payouts / FCF | 60.5% | 11.8% | 58.9% | 13.8% | 14.1% | 19.0% | 53.0% | 14.9% | 27.7% | 43.0% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 8.0 | 6.0 | 6.0 | 5.0 | 7.0 | 7.0 | 7.0 | 5.0 | 7.0 |
| Altman Z'' | 4.6 | 4.7 | 4.4 | 4.5 | 5.2 | 4.7 | 5.2 | 4.4 | 5.5 | 5.4 |
| Accruals ratio | β3.6% | β2.0% | β1.8% | β2.7% | β4.0% | β1.5% | 0.1% | β3.1% | β3.1% | β2.1% |
Source: SEC EDGAR XBRL filings (CIK 0001037868). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.